Skip to content
Twitter Facebook-f Youtube Instagram Linkedin
NETs Info
Donate
Close Menu
  • Who We Are
    • About Us
    • Our People
    • Our Board
    • Our Ambassadors
    • Consumer Advisory Group
    • International Advisory Panel
    • Governance & Policy
  • Neuroendocrine Cancers
    • What are Neuroendocrine Cancers?
    • Patient Resources
    • Pheos and Paras
    • NET Library
  • I Am a Patient
    • Patient Support
    • Patient Resources
    • NET Nurse
    • Patient Stories
    • Australian NET Specialists
    • Current Clinical Trials
  • I am a HCP
    • Professional Learning
    • HCP – Patient Referral to NET Nurse
    • Current Clinical Trials
    • NET Library
    • HCP Newsletter & Signup
    • Australian NET Specialists
    • Request an In-Service
    • PLANET Registry
    • Order booklets and other resources
  • Get Involved
    • Advocate for us
    • Share your story
    • Donate
    • Fundraise
    • In Memoriam
    • Corporate Partners
    • Gifts & Wills
    • Workplace Giving
    • Volunteer
  • What’s On
    • News
    • Newsletter & Signup
    • INCA Newsletter archive
    • Events
  • Shop
  • Contact Us
Donate
  • Who We Are
    • About Us
    • Our People
    • Our Board
    • Our Ambassadors
    • Consumer Advisory Group
    • International Advisory Panel
    • Governance & Policy
  • Neuroendocrine Cancers
    • What are Neuroendocrine Cancers?
    • Patient Resources
    • Pheos and Paras
    • NET Library
  • I Am a Patient
    • Patient Support
    • Patient Resources
    • NET Nurse
    • Patient Stories
    • Australian NET Specialists
    • Current Clinical Trials
  • I am a HCP
    • Professional Learning
    • HCP – Patient Referral to NET Nurse
    • Current Clinical Trials
    • NET Library
    • HCP Newsletter & Signup
    • Australian NET Specialists
    • Request an In-Service
    • PLANET Registry
    • Order booklets and other resources
  • Get Involved
    • Advocate for us
    • Share your story
    • Donate
    • Fundraise
    • In Memoriam
    • Corporate Partners
    • Gifts & Wills
    • Workplace Giving
    • Volunteer
  • What’s On
    • News
    • Newsletter & Signup
    • INCA Newsletter archive
    • Events
  • Shop
  • Contact Us

Home » General » World NET Cancer Day November 10

World NET Cancer Day November 10

  • November 5, 2015
November 10 is World NET Awareness Day and we need your help! Use your social media accounts to help us raise awareness about NET Cancer and highlight the issue for people living with NETs.

TWITTER
Twitter handle:       @netcancerday
                               @unicornfound
Hashtag:                  #netcancerday
Additional hashtags (if needed):    #netcancer
                                                      #neuroendocrine
                                                      #incalliance 

Maximum message length: 140 characters, however best to use only 120 characters so people can retweet your message easily with RT @netcancerday in front of the post.

Search for politicians, celebrities, media to tag in your tweets.

Change your profile picture to our NET CANCER ribbon

 

Share the messages with your friends and followers

Key messages: 
• 5-7 out of every 100.000 are diagnosed with #netcancer each year  http://incalliance.org
• 50% of #netcancer patients have secondary growths at diagnosis http://incalliance.org
• 60-80% of patients are diagnosed with #NETCANCER at advanced stage showing the need for symptom awareness http://incalliance.org
• Misdiagnosing is common. On average #netcancer patients see 6 healthcare professionals over 12 visits before a correct diagnosis http://incalliance.org
• Symptoms of #netcancer are often similar to more common conditions: IBS, asthma, diabetes http://incalliance.org
• #netcancer can arise throughout the body in organs that contain #neuroendocrine cells such as the stomach, bowel, lungs, pancreas http://incalliance.org
• Nearly all #NETCANCER are considered to be malignant as they grow uncontrollably and spread http://incalliance.org
• More than 80% of #netcancer patients stopped working as a result of their cancer http://incalliance.org
• Patients treated in a #netcancer specialist centre feel more empowered and knowledgeable about their treatment and care http://incalliance.org
• The incidence of #neuroendocrine cancer is low, but #netcancer patients are everywhere. Thankfully, many live long & happy lives. #netcancerday http://incalliance.org
• Over 1000 events held throughout the world on November 10th to promote awareness of #netcancerday http://incalliance.org
• #netcancer if you don’t suspect it you can’t detect it #netcancerday http://incalliance.org
• If you're organizing an event for NET Cancer Awareness Day, share it by tweeting to @netcancerday http://incalliance.org
• More than 8,000 people signed our petition to promote awareness of #neuroendocrine tumors #netcancer. Sign our petition http://netcancerday.org

Share this post

Subscribe to our eNews

Stay up to date on news and events, clinical trials and new research on neuroendocrine cancers.

Recent posts

World Cancer Day 2023

January 10, 2023

Support Groups Christmas Gatherings

December 20, 2022

NeuroEndocrine Cancer Australia & Norman Family Trust Partnership

December 14, 2022

NeuroEndocrine Cancer Australia partners with Gathered Here to provide the NET community with free online Wills

December 14, 2022
Categories
  • Advocacy
  • Awareness
  • Community Events
  • Education
  • Events
  • Fundraising
  • General
  • In The Media
  • News
  • Research
  • Unicorn Events
PrevPreviousUF welcomes NET Patient Support Nurse Kate Wakelin
NextNew online chat sessions for NET PatientsNext

Related Posts

NECA Finalist as NGO of the Year in Prime Awards

We’re thrilled to be announced as one of the finalists in the NGO of The Year category in the 2022 PRIME Awards Australia. The Prime

COVID-19 Information and Resources

A note from our CEO on COVID-19: To our wonderful NET community we stand with you and alongside you as we get through this unprecedented

Expression-of-Interest for consumer participation on Grant Review Committees for the 2022 Priority-driven Collaborative Cancer Research Scheme

Cancer Australia’s Priority-driven Collaborative Cancer Research Scheme (PdCCRS) is an innovative, competitive, annual cancer research projects grant funding scheme. The PdCCRS is conducted by Cancer

32 neuroendocrine tumour presentations at ASCO annual scientific conference

The ASCO Annual Conference was held virtually this year from 29 – 31 May 2020 with 32 Neuroendocrine presentations from this meeting delivered orally, by

View All

Make a difference

How much do you wish to donate?
$50
$100
$250
$500
$1000
Other
NeuroEndocrine Cancer Australia logo white
Twitter Facebook-f Youtube Instagram Linkedin

All donations are tax deductible.
Registered Charity CFN 202607

Who We Are

  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies
  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies

Neuroendocrine Cancers

  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library
  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library

For Patients

  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials
  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials

Get Involved

  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise
  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise

© 2020 NeuroEndocrine Cancer Australia

  • Website by Five Creative